Duncan Gilmour
Analyst · Lake Street Capital Markets
Thank you, Rich. Starting on Slide 6. On a sequential basis, revenue in Q2 increased $1.4 million or 4% from $33.9 million in Q1 to $35.3 million. The net increase was driven almost entirely by Auto/EV, which increased by $6 million on the shipment of high revenue, lower-margin Alfamation automotive projects from backlog. Industrial contributed $1.1 million. Partially offsetting these gains was a $2.1 million decline in defense/aerospace following a particularly strong first quarter as well as decreases of $1.6 million in Life Sciences and $1.4 million in semi. Compared to Q2 2025, revenues increased $7.2 million or 26% from $28.1 million. The increase over the prior year period reflects the continued gradual recovery in the capital spending environment and continued penetration of non-semi-correlated end markets. Non-semi markets accounted for approximately 74% of Q2 revenue. Sales in Auto/EV increased $7.6 million, followed by Life Sciences and Industrial at approximately $0.6 million each. Partially offsetting these gains was a $1.1 million decline in semi. Turning to Slide 7. Second quarter gross profit was $14.3 million and gross margin was 40.5%. Compared to revised Q1 results, gross margin declined 280 basis points sequentially, reflecting a shift in revenue mix towards high revenue, lower-margin Auto/EV shipments. For the same reason, gross margin declined 210 basis points from 42.6% in the prior year period. Moving on to Slide 8. Operating expenses for the second quarter were $13.9 million, a decrease of $0.5 million sequentially. The sequential decrease was due primarily to approximately $0.7 million in nonrecurring restructuring costs associated with the CEO transition that we recorded in Q1 and did not recur in the second quarter. On a year-over-year basis, we generated $7.2 million of incremental revenue while absorbing only $1 million of incremental operating expenses, which resulted in a reduction in operating expenses as a percentage of revenue to 39.5%. Turning to Slides 9 and 10 that collectively measure our profitability. On Slide 9, for Q2, net income was $0.5 million, representing a net margin of 1.3%. Adjusted EBITDA was $2.2 million, representing an adjusted EBITDA margin of 6.2% and up approximately 73% from $1.3 million in Q2 of 2025. On Slide 10, net income was $0.04 per diluted share. Adjusted EPS, which adds back tax-affected acquired intangible amortization and restructuring charges, was $0.09 per diluted share. Our Q2 results include a discrete income tax benefit of approximately $0.02 per diluted share that is driven by stock option exercises during the quarter. This benefit is specific to the second quarter, but we continue to expect a full year effective tax rate of approximately 18%. Slide 11 shows our capital structure and cash flow. We ended the second quarter with cash and cash equivalents of $22.1 million, an increase of $6.4 million from the end of Q1. During the second quarter, we generated $6.3 million of cash from operating activities and received $2.9 million in proceeds from stock option exercises. These inflows were partially offset by $2.3 million of net debt repayments, including a $1 million reduction in term debt and by $0.4 million of capital expenditures. At June 30, 2026, we had approximately $62 million in total liquidity. In addition to $22.1 million of cash and equivalents, we had $40 million of available borrowing capacity under our delayed draw term loan and revolving credit facilities, which we have extended through August 28, 2026. Total debt was $6.2 million, and our leverage ratio was 0.8x trailing 12-month adjusted EBITDA. Turning to Slide 12 and our financial guidance for the year. We are introducing guidance for Q3 and are reiterating the outlook we provided on July 31. For Q3, we project revenue of $33 million to $35 million, gross margin of approximately 44%, operating expenses of $13.8 million to $14.2 million and amortization of $0.5 million. For the full year, we now expect revenue of $135 million to $140 million. At the midpoint, this represents growth of approximately 21% over 2025's $113.8 million. This increased revenue guidance reflects continued diversified demand supported by our backlog and improving order flow and outlook into the second half, particularly in semi sales. Gross margin, approximately 43%, operating expenses of $55 million to $57 million, amortization of $2.6 million and interest expense of approximately $0.3 million with an effective tax rate estimated to be 18%. And finally, we expect capital expenditures of 1% to 2% of revenue, consistent with our historical investment levels. This guidance excludes any potential acquisitions and restructuring costs and assumes our view of macroeconomic conditions remain unchanged through the end of the year. Finally, a brief word on internal controls. In connection with the Q1 revision on July 31, management and our Audit Committee concluded that the control deficiencies underlying the revision at Alfamation constituted a material weakness in our internal control over financial reporting. We have implemented remediation plans and fully expect to demonstrate that these controls are operating effectively by fiscal year-end. This is described more fully in our Form 10-Q that will be filed later today. With that, if you turn to Slide 13, I will now turn the call back over to Rich.